72 related articles for article (PubMed ID: 38653823)
1. Integrating tumor and healthy epithelium in a micro-physiology multi-compartment approach to study renal cell carcinoma pathophysiology.
Somova M; Simm S; Padmyastuti A; Ehrhardt J; Schoon J; Wolff I; Burchardt M; Roennau C; Pinto PC
Sci Rep; 2024 Apr; 14(1):9357. PubMed ID: 38653823
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-15 plays a central role in human kidney physiology and cancer through the γc signaling pathway.
Giron-Michel J; Azzi S; Khawam K; Mortier E; Caignard A; Devocelle A; Ferrini S; Croce M; François H; Lecru L; Charpentier B; Chouaib S; Azzarone B; Eid P
PLoS One; 2012; 7(2):e31624. PubMed ID: 22363690
[TBL] [Abstract][Full Text] [Related]
3. Human Renal Normal, Tumoral, and Cancer Stem Cells Express Membrane-Bound Interleukin-15 Isoforms Displaying Different Functions.
Azzi S; Gallerne C; Romei C; Le Coz V; Gangemi R; Khawam K; Devocelle A; Gu Y; Bruno S; Ferrini S; Chouaib S; Eid P; Azzarone B; Giron-Michel J
Neoplasia; 2015 Jun; 17(6):509-17. PubMed ID: 26152359
[TBL] [Abstract][Full Text] [Related]
4. Relationship between expression of drug-resistance factors and drug sensitivity in normal human renal proximal tubular epithelial cells in comparison with renal cell carcinoma.
Asakura T; Imai A; Ohkubo-Uraoka N; Kuroda M; Iidaka Y; Uchida K; Shibasaki T; Ohkawa K
Oncol Rep; 2005 Sep; 14(3):601-7. PubMed ID: 16077962
[TBL] [Abstract][Full Text] [Related]
5. TNF-α augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma.
Sun KH; Sun GH; Wu YC; Ko BJ; Hsu HT; Wu ST
J Cell Mol Med; 2016 Nov; 20(11):2020-2028. PubMed ID: 27297979
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Characterization of Renal Drug Transporter Activity in Kidney Cancer.
Caetano-Pinto P; Justian N; Dib M; Fischer J; Somova M; Burchardt M; Wolff I
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077583
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic-based prostate cancer model for investigating the secretion of prostate-specific antigen and microRNAs in vitro.
Padmyastuti A; Sarmiento MG; Dib M; Ehrhardt J; Schoon J; Somova M; Burchardt M; Roennau C; Pinto PC
Sci Rep; 2023 Jul; 13(1):11623. PubMed ID: 37468746
[TBL] [Abstract][Full Text] [Related]
8. Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma.
Lasorsa F; Rutigliano M; Milella M; Ferro M; Pandolfo SD; Crocetto F; Tataru OS; Autorino R; Battaglia M; Ditonno P; Lucarelli G
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373581
[TBL] [Abstract][Full Text] [Related]
9. Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice.
Lasorsa F; di Meo NA; Rutigliano M; Milella M; Ferro M; Pandolfo SD; Crocetto F; Tataru OS; Autorino R; Battaglia M; Ditonno P; Lucarelli G
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189689
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Tumor Immune Microenvironment in Renal Cell Carcinoma.
Shapiro DD; Dolan B; Laklouk IA; Rassi S; Lozar T; Emamekhoo H; Wentland AL; Lubner MG; Abel EJ
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173966
[TBL] [Abstract][Full Text] [Related]
11. Trends in cause of death among patients with renal cell carcinoma in the United States: a SEER-based study.
Zhan X; Chen T; Liu Y; Wan H; Liu X; Deng X; Fu B; Xiong J
BMC Public Health; 2023 Apr; 23(1):770. PubMed ID: 37101189
[TBL] [Abstract][Full Text] [Related]
12. The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery.
di Meo NA; Lasorsa F; Rutigliano M; Milella M; Ferro M; Battaglia M; Ditonno P; Lucarelli G
Expert Rev Mol Diagn; 2023 Apr; 23(4):297-313. PubMed ID: 36960789
[TBL] [Abstract][Full Text] [Related]
13. MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation.
Lucarelli G; Netti GS; Rutigliano M; Lasorsa F; Loizzo D; Milella M; Schirinzi A; Fontana A; Di Serio F; Tamma R; Ribatti D; Battaglia M; Ranieri E; Ditonno P
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902242
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
